Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sentinel Node and Organ-sparing Surgery in Stage I Colon Carcinoma (SENTRY Trial)

NCT06652672 is registered in ClinicalTrials.gov with Meander Medical Center as lead sponsor.

NCT NCT06652672
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06652672 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sentinel Node and Organ-sparing Surgery in Stage I Colon Carcinoma (SENTRY Trial)
Lead sponsor
Meander Medical Center
Phase
Not applicable
Overall status
Recruiting
Start date
December 12, 2024
Completion date
December 12, 2032
Enrollment
341 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colon adenocarcinoma, colon cancer, colon neoplasm, colon neoplasms, colon surgery, fluorescence, fluorescence guided surgery, fluorescence laparoscopy, fluorescence-guided resection, indocyanine green (icg), sentinel lymph node, sentinel lymph node biopsy